JP2008532014A5 - - Google Patents

Download PDF

Info

Publication number
JP2008532014A5
JP2008532014A5 JP2007557159A JP2007557159A JP2008532014A5 JP 2008532014 A5 JP2008532014 A5 JP 2008532014A5 JP 2007557159 A JP2007557159 A JP 2007557159A JP 2007557159 A JP2007557159 A JP 2007557159A JP 2008532014 A5 JP2008532014 A5 JP 2008532014A5
Authority
JP
Japan
Prior art keywords
useful
epitopes
epitopes according
useful epitopes
nisch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007557159A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008532014A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/006431 external-priority patent/WO2006091734A2/en
Publication of JP2008532014A publication Critical patent/JP2008532014A/ja
Publication of JP2008532014A5 publication Critical patent/JP2008532014A5/ja
Withdrawn legal-status Critical Current

Links

JP2007557159A 2005-02-24 2006-02-24 生物試料を分類するための組成物及び方法 Withdrawn JP2008532014A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65685905P 2005-02-24 2005-02-24
PCT/US2006/006431 WO2006091734A2 (en) 2005-02-24 2006-02-24 Compositions and methods for classifying biological samples

Publications (2)

Publication Number Publication Date
JP2008532014A JP2008532014A (ja) 2008-08-14
JP2008532014A5 true JP2008532014A5 (enExample) 2009-04-16

Family

ID=36928007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007557159A Withdrawn JP2008532014A (ja) 2005-02-24 2006-02-24 生物試料を分類するための組成物及び方法

Country Status (11)

Country Link
US (1) US20090075832A1 (enExample)
EP (1) EP1859266A4 (enExample)
JP (1) JP2008532014A (enExample)
KR (1) KR20080003321A (enExample)
CN (1) CN101160524A (enExample)
AU (1) AU2006216683A1 (enExample)
CA (1) CA2598889A1 (enExample)
IL (1) IL185458A0 (enExample)
MX (1) MX2007010349A (enExample)
RU (1) RU2007135030A (enExample)
WO (1) WO2006091734A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842480B2 (en) 2001-05-18 2010-11-30 Mayo Foundation For Medical Education And Research Chimeric antigen-specific t cell-activating polypeptides
US20060222656A1 (en) 2005-04-01 2006-10-05 University Of Maryland, Baltimore MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
JP5564249B2 (ja) * 2006-06-23 2014-07-30 アレシア・バイオセラピューティクス・インコーポレーテッド 癌に関与するポリヌクレオチド配列およびポリペプチド配列
WO2008053573A1 (fr) 2006-10-30 2008-05-08 National University Corporation Hokkaido University Remède pour néoplasme malin
TWI615403B (zh) * 2007-02-21 2018-02-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
EP2201024A1 (en) 2007-08-28 2010-06-30 Ramot At Tel Aviv University Peptides inducing a cd4i conformation in hiv gp120 while retaining vacant cd4 binding site
TWI466680B (zh) * 2008-08-01 2015-01-01 Oncotherapy Science Inc Ｍｅｌｋ抗原決定位胜肽及含此胜肽的疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
WO2010060186A1 (en) 2008-11-03 2010-06-03 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
GB0823366D0 (en) * 2008-12-22 2009-01-28 Uni I Oslo Synthesis
KR101067815B1 (ko) * 2009-02-05 2011-09-27 서울대학교산학협력단 제1형 당뇨병의 신규한 진단 마커
EP3444613B1 (en) 2009-08-14 2021-05-19 The Regents of The University of California Methods of diagnosing and treating autism
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
TWI485245B (zh) * 2010-01-25 2015-05-21 Oncotherapy Science Inc 經修飾之ｍｅｌｋ胜肽及含此胜肽之疫苗
JP6294221B2 (ja) 2011-03-31 2018-03-14 アー・デー・ツェー・セラピューティクス・エス・アー 腎臓関連抗原１に対する抗体およびその抗原結合性フラグメント
EP2745115B1 (de) * 2011-08-19 2016-05-18 Protagen AG Neues verfahren zur diagnostik von hochaffinen bindern und markersequenzen
WO2013031757A1 (ja) * 2011-08-29 2013-03-07 東レ株式会社 膵癌、乳癌、肺癌又は前立腺癌の検出用マーカー及び検査方法
TR201908872T4 (tr) 2012-01-09 2019-07-22 Adc Therapeutics Sa Üçlü negatif meme kanserini tedavi etmek için ajanlar.
US20130183242A1 (en) * 2012-01-18 2013-07-18 University Of Connecticut Methods for identifying tumor-specific polypeptides
GB201319446D0 (en) 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors
WO2015172843A1 (en) * 2014-05-16 2015-11-19 Biontech Diagnostics Gmbh Methods and kits for the diagnosis of cancer
EP3145516A4 (en) * 2014-05-20 2018-06-13 Kiromic, LLC Methods and compositions for treating malignancies with dendritic cells
AU2016209247B2 (en) 2015-01-21 2021-02-25 Inhibrx Biosciences, Inc. Non-immunogenic single domain antibodies
GB201505305D0 (en) * 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
EP4300101A3 (en) 2015-06-26 2024-03-20 The Regents Of The University Of California Antigenic peptides and uses thereof for diagnosing and treating autism
EP3322734B1 (en) 2015-07-16 2020-09-09 Inhibrx, Inc. Multivalent and multispecific dr5-binding fusion proteins
HK1258386A1 (zh) 2015-10-05 2019-11-08 Immatics Biotechnologies Gmbh 用於小细胞肺癌和其他癌症免疫治疗的肽和肽组合物
EP3193173A1 (en) * 2016-01-14 2017-07-19 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Serological autoantibodies as biomarker for colorectal cancer
GB201604458D0 (en) * 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against cancers
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung
ES2946584T3 (es) * 2017-01-27 2023-07-21 Immatics Biotechnologies Gmbh Nuevos péptidos y nuevas combinaciones de péptidos para el uso en la inmunoterapia contra el cáncer de ovario y otros tipos de cáncer
CN108948184B (zh) * 2017-05-22 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别衍生自prame抗原短肽的t细胞受体
CN109400697B (zh) * 2017-08-17 2021-04-23 香雪生命科学技术（广东）有限公司 一种识别prame抗原短肽的tcr及其相关组合物
EP3756680A1 (en) * 2019-06-26 2020-12-30 Universitat de Lleida Intermediate filament-derived peptides and their uses
EP3999525A4 (en) * 2019-07-15 2023-08-09 Geisinger Health System COMPOSITIONS AND METHODS FOR THE TREATMENT OF BREAST CANCER WITH A NOVEL CAPER ALPHA MLL1 COMPLEX
CN110922492B (zh) * 2019-12-18 2022-02-15 重庆医科大学 融合肽、ctp介导的诱导cml细胞免疫应答的dc疫苗及其制备方法
CN111337678B (zh) * 2020-02-21 2023-06-06 杭州凯保罗生物科技有限公司 与肿瘤免疫治疗效果相关的生物标志物及其应用
CN116773798A (zh) * 2023-06-16 2023-09-19 北京三品医疗科技有限公司 多肽的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
CA2432639A1 (en) * 2000-11-16 2002-05-23 Cemines, Llc Profiling tumor specific markers for the diagnosis and treatment of neoplastic disease
AU2002302410A1 (en) * 2001-03-10 2002-09-24 Affina Immuntechnik Gmbh Method for identifying immune reactive epitopes on proteins
JP4594588B2 (ja) * 2001-04-10 2010-12-08 ザ ボード オブ トラスティーズ オブ ザ リランド スタンフォード ジュニア ユニヴァーシティ 抗体特異的プロファイルの治療的および診断的使用方法
AU2002347778A1 (en) * 2001-09-28 2003-05-26 Incyte Genomics, Inc. Enzymes
WO2004058972A1 (de) * 2002-12-23 2004-07-15 Thiesen Hans-Juergen Human-autoantigene und deren verwendung
JP2006524035A (ja) * 2002-12-26 2006-10-26 シーマインズ リミテッド ライアビリティ カンパニー 癌の診断、予後診断および治療のための方法および組成物

Similar Documents

Publication Publication Date Title
JP2008532014A5 (enExample)
RU2007135030A (ru) Композиции и способы классификации биологических образцов
Lin et al. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes
Makretsov et al. Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma
CN103826750B (zh) 从血液中捕获和检测循环多发性骨髓瘤的测定法
Hao et al. Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters
JP2012508865A5 (enExample)
Soltys et al. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers
JP2009538607A5 (enExample)
Caprioli Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy
Mok et al. Association of kidney disease measures with cause-specific mortality: the Korean Heart Study
JP2009522578A5 (enExample)
Los-de Vries et al. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
TW201840854A (zh) 準確診斷牙科疾病的方法與設備
JP2015518152A (ja) 前立腺がんの検出用バイオマーカーの定量
JP2017195803A (ja) 早期胃癌検出キット及び早期胃癌細胞の検出方法
JP2008502332A5 (enExample)
Hofman Liquid biopsy for lung cancer screening: usefulness of circulating tumor cells and other circulating blood biomarkers
JP2013506837A5 (enExample)
JP2016531596A (ja) 循環している癌のバイオマーカー及びその使用
JP2010526995A5 (enExample)
Benhammou et al. DETECT: development of technologies for early HCC detection
Harris et al. Quest for the ideal cancer biomarker: an update on progress in capture and characterization of circulating tumor cells
JP2015505359A5 (enExample)
JP2013513812A5 (enExample)